Vitamin D deficiency in pregnancy and gestational diabetes: Burris et al

2012 ◽  
Vol 207 (3) ◽  
pp. 235-236
Author(s):  
George A. Macones ◽  
Shayna Norman ◽  
Margaret Hopeman ◽  
Stephen A. McCartney
2021 ◽  
Vol 17 (1) ◽  
pp. 63-69
Author(s):  
A. Konwisser ◽  
O. Korytko

Results show vitamin D supplementation during pregnancy improves maternal and infant 25(OH)D concentrations and may play a role in maternal insulin resistance and fetal growth. Literature search was performed using PubMed Database of the National Library of Medicine, with date limits from January 2015 to November 2020. We used the keywords: Vitamin D, pregnancy, vitamin D supplementation, hypovitaminosis D, preeclampsia, gestational diabetes, preterm birth, and other related terms. The studies of interest included original papers and review articles on the influence of vitamin D deficiency in pregnancy and the impact of vitamin D supplementation on the maternal outcomes. The published Cochrane review on vitamin D supplementation studies reported that women who receive vitamin D supplementation had lower risk of preeclampsia but with only borderline significance (RR 0.52, CI 0.25–1.05), whereas combined vitamin D and calcium supplementation significantly reduces the risk of preeclampsia. The overall level of evidence is high for vitamin D supplementation playing no role in the prevention of gestational diabetes. Although analysis of the recent observational studies suggests that vitamin D deficiency can increase the risk of C section, there is a need for investigators to conduct RCT to study the impact of vitamin D supplementation on C-section rates. Maternal vitamin D status closest to the delivery was most significantly associated with preterm birth, thereby proposing that later intervention could be used as a rescue treatment to decrease the risk of preterm deliveries. Though the level of evidence is moderate, our analysis shows no significant association between vitamin D and preterm deliveries. Many studies have been designed to investigate an association between postpartum depression and vitamin D. To determine the benefits of vitamin D supplementation in pregnancy would require further evaluation through large, multicenter double-blind randomized controlled clinical trials, with a focus on specific adverse pregnancy outcomes.


2012 ◽  
Vol 207 (3) ◽  
pp. 182.e1-182.e8 ◽  
Author(s):  
Heather H. Burris ◽  
Sheryl L. Rifas-Shiman ◽  
Ken Kleinman ◽  
Augusto A. Litonjua ◽  
Susanna Y. Huh ◽  
...  

2012 ◽  
Vol 207 (3) ◽  
pp. e1-e3 ◽  
Author(s):  
George A. Macones ◽  
Shayna Norman ◽  
Margaret Hopeman ◽  
Stephen A. McCartney

2007 ◽  
Vol 197 (6) ◽  
pp. S194
Author(s):  
Donna Johnson ◽  
Carol Wagner ◽  
Myla Ebeling ◽  
Thomas Hulsey ◽  
Bruce Hollis

2016 ◽  
Vol 19 (11) ◽  
pp. 8
Author(s):  
Charmaine Silveira Da Graca Costa ◽  
Kathryn Hoffmann

2019 ◽  
Vol 09 (03) ◽  
pp. e226-e234
Author(s):  
Anna Maya Powell ◽  
Judy R. Shary ◽  
Christopher Louden ◽  
Vishwanathan Ramakrishnan ◽  
Allison Ross Eckard ◽  
...  

Objective Bacterial vaginosis (BV) is associated with vitamin D deficiency and poor pregnancy outcomes. We studied a nested cohort from a randomized controlled trial to investigate the association between BV and vitamin D concentration in pregnancy. Study Design Subjects with randomly assigned 400 versus 4,400 IU of daily cholecalciferol (vitamin D3) had vaginal swabs collected for Gram staining and Nugent score calculation, as well as plasma 25-hydroxyvitamin D (25(OH)D) measurement at three pregnancy time points. Results Fifty-two (21.2%) of the 245 women included in the analysis were diagnosed with BV at study entry. Women with BV were also more likely to be African American (p < 0.0001) and have lower 25(OH)D concentrations at 22 to 24 weeks' gestation (p = 0.03). There were no differences in pregnancy outcomes of interest within this group compared with the remaining study subjects. In mixed regression modeling, while race (p = 0.001) and age (p = 0.03) were significant predictors of BV prevalence independently, 25(OH)D concentration (p = 0.81), gestational age (p = 0.06), and body mass index (p = 0.87) were not. Conclusion Neither vitamin D deficiency in early pregnancy nor supplementation decreased BV incidence during pregnancy. Pregnancy outcomes (preterm birth and hypertensive disorders of pregnancy) were similar among women with and without BV.


Sign in / Sign up

Export Citation Format

Share Document